3rd generation glp 1 agonist GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease GLP-1 Receptor Agonists as Treatments

An area of interest for GLP-1 agents is their potential use in treating polycystic ovarian syndrome (PCOS)

Waste Manag 54:4452

Chemistry and receptor pharmacology of SLU-PP-332 SLU-PP-332 is a drug-like small molecule that shows submicromolar to low-nanomolar activation potency for ERRs in reporter assays, with the strongest activity at ERR and meaningful activation of ERR/

If your TRT check-in consists of a single total testosterone number and a quick "how do you feel," you are not getting the oversight your health deserves

A total of 14 years in dedicated schooling and medical residency

Who leads the GLP-1 Adherence Platforms Market